Why Navidea Biopharmaceuticals Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | April 14, 2023 08:26am

Gainers

• CXApp Inc. (NASDAQ:CXAI) jumped 318% to $29.80 in pre-market trading after gaining more than 345% on Thursday.
• SAI.TECH Global Corporation (NASDAQ:SAI) gained 211% to $4.73 in pre-market trading after gaining around 25% on Thursday.
• Inpixon (NASDAQ:INPX) surged 106% to $1.49 in pre-market trading after jumping around 128% on Thursday.
• Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) climbed 98.2% to $2.24 in pre-market trading.
• SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares climbed 54.3% to $3.50 in pre-market trading after jumping 37% on Thursday.
• Marpai, Inc. (NASDAQ:MRAI) gained 41% to $2.30 in pre-market trading after gaining 90% on Thursday.
• LogicMark, Inc. (NASDAQ:LGMK) gained 24.7% to $0.1970 in pre-market trading after gaining around 8% on Thursday.
• G Medical Innovations Holdings Ltd (NASDAQ:GMVD) gained 23.7% to $0.6572 in pre-market trading. G Medical Innovations recently announced closing of public offering.
• Navidea Biopharmaceuticals, Inc. (NASDAQ:NAVB) gained 16.5% to $0.3035 in pre-market trading. Navidea Biopharmaceuticals entered into $750,000 asset purchase agreement with Meilleur Technologies for rights to NAV4694.
• Freight Technologies, Inc. (NASDAQ:FRGT) climbed 15.7% to $3.02 in pre-market trading after declining 9% on Thursday. Freight Technologies recently regained compliance with Nasdaq listing rule.

Losers

• Navidea Biopharmaceuticals (NASDAQ:NCMI) fell 27% to $0.3124 in pre-market trading. The company recently filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas. The company announced a series of debt restructuring transactions likely to strengthen its balance sheet meaningfully and position it for long-term growth.
• Pear Therapeutics, Inc. (NASDAQ:PEAR) shares dropped 24.4% to $0.0896 in pre-market trading. Pear Therapeutics recently filed for Chapter 11 and said it will seek to sell its assets through a sales process.
• PARTS iD, Inc. (NYSE:ID) fell 21.9% to $0.1926 in pre-market after dropping over 5% on Thursday.
• SAB Biotherapeutics, Inc. (NASDAQ:SABS) fell 20.5% to $0.6029 in pre-market trading. SAB Therapeutics shares jumped around 98% on Thursday after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza.
• Meta Materials Inc. (NASDAQ:MMAT) fell 20.2% to $0.3050 in pre-market trading after the company reported a proposed public offering.
• Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 18.8% to $0.47 in pre-market trading. Panbela Therapeutics recently announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
• Kalera Public Limited Company (NASDAQ:KAL) fell 17.3% to $1.34 in pre-market trading after dropping 14% on Thursday. Kalera recently received a notice of delisting form Nasdaq.
• Wheels Up Experience Inc. (NYSE:UP) fell 17.1% to $0.44 in pre-market trading after gaining around 27% on Thursday.
• HeartCore Enterprises, Inc. (NASDAQ:HTCR) fell 15.1% to $1.01 in pre-market trading after dropping 15% on Thursday. HeartCore Enterprises recently announced it signed its tenth Go IPO contract.
• Knightscope, Inc. (NASDAQ:KSCP) shares fell 13.6% to $0.55 in pre-market trading after dropping over 6% on Thursday.

Now Read This: S&P 500 Settles Higher Ahead Of Bank Earnings, Market Volatility Decreases

Posted In: CXAI FRGT GMVD HTCR ID INPX KAL KSCP LGMK MMAT MRAI NAVB NCMI PBLA PEAR PTPI SABS SAI SMX UP